GlassScriptPhysician profile
Matthew Adam Heller
NPI 1750677415
$7,072.06
in general payments reported to CMS, 2019-2025
13 companies · $1,934 in 2025
The $1,934 reported for 2025 was more than what 88% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,178 · 2020: $614 · 2021: $1,121 · 2022: $590 · 2023: $934 · 2024: $701 · 2025: $1,934.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,568.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $3,308.94 | 2020-2025 | Idosetr, Idose Tr, Istent Infinite |
| Johnson & Johnson Surgical Vision, INC. | $1,648.77 | 2019-2024 | Tecnis Simplicity, Veritas Vision System, Tecnis Iol |
| Lensar, INC. | $717.46 | 2025 | Lensar Laser System |
| Alcon Vision LLC | $417.00 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $239.17 | 2023-2025 | Teneo, Envista Mx60 Iol, Stellaris |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $199.28 | 2019 | |
| Rxsight INC | $155.82 | 2024-2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Johnson & Johnson Vision Care, INC. | $122.89 | 2024 | Acuvue |
| Novartis Pharmaceuticals Corporation | $106.32 | 2020 | |
| Ge Healthcare | $60.39 | 2020 | |
| Carl Zeiss Meditec USA, INC. | $48.92 | 2024 | |
| Dompe US, INC. | $28.09 | 2025 | Oxervate |
| Abbvie INC. | $19.01 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Heller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.